On the 13th, a team from Mackay Children's Hospital announced the results of a 10-year study, finding that through newborn screening, the average age of diagnosis for mucopolysaccharidosis can be reduced from 4.3 years to about 0.2 years, giving children the opportunity to receive treatment before symptoms appear, thus reducing damage to bones, organs, and neurocognitive functions.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
On the 13th, a team from Mackay Children's Hospital announced the results of a 10-year study, finding that through newborn screening, the average age of diagnosis for mucopolysaccharidosis can be reduced from 4.3 years to about 0.2 years, giving children the opportunity to receive treatment before symptoms appear, thus reducing damage to bones, organs, and neurocognitive functions.